Fluoro-norchloroepibatidine: Preclinical assessment of acute toxicity
- 1 November 1997
- journal article
- Published by Elsevier in Nuclear Medicine and Biology
- Vol. 24 (8), 743-747
- https://doi.org/10.1016/s0969-8051(97)00120-0
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Synthesis of [18F]norchlorofluoroepibatidine and its N-methyl derivative: new PET ligands for mapping nicotinic acetylcholine receptorsJournal of Labelled Compounds and Radiopharmaceuticals, 1997
- Mapping nicotinic acetylcholine receptors with PETSynapse, 1996
- Tolerance to the antinociceptive effect of epibatidine after acute and chronic administration in miceEuropean Journal of Pharmacology, 1996
- Synthesis of a radiotracer for studying nicotinic acetylcholine receptors: (+/−)-exo-2-(2-[18F]fluoro-5-pyridyl)-7-azabicyclo[2.2.1]heptaneJournal of Labelled Compounds and Radiopharmaceuticals, 1996
- RESUSCITATION WITH LACTATED RINGERʼS SOLUTION AFTER HEMORRHAGEShock, 1996
- Response to Monro and Mehta proposal for use of single-dose toxicology studies to support single-dose studies of new drugs in humansClinical Pharmacology & Therapeutics, 1996
- In vivo labeling of neuronal nicotinic acetylcholine receptors with radiolabeled isomers of norchloroepibatidineNeuroReport, 1995
- In vivo labeling of nicotinic acetylcholine receptors in brain with [3H]epibatidineEuropean Journal of Pharmacology, 1995
- Differential hemodynamic, metabolic and hormonal effects of morphine and morphine-6-glucuronideBrain Research, 1994
- Pharmacological effects of epibatidine optical enantiomersBrain Research, 1994